BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 69
- 較 2023 年第 2 季 +2
- 總值
- $37.1 億
- 較 2023 年第 2 季 +$1.21 億 (+3.4%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 21,751,284 | $12.4 億 | 33.4% | 00.0% | 不變 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 4,004,613 | $1.82 億 | 4.9% | +1,158,598+40.7% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 2,131,100 | $1.49 億 | 4.0% | 00.0% | 不變 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 5,283,489 | $1.43 億 | 3.8% | −400,000−7.0% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 4,370,024 | $1.38 億 | 3.7% | +4,370,024 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 9,135,893 | $1.13 億 | 3.0% | +1,524,390+20.0% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 3,981,212 | $1.10 億 | 3.0% | −2,274,376−36.4% | 減碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 8,291,988 | $1.00 億 | 2.7% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 5,744,848 | $9,582 萬 | 2.6% | +1,968,948+52.1% | 加碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $9,322 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,750,000 | $8,824 萬 | 2.4% | 00.0% | 不變 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 10,563,748 | $7,046 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,915,109 | $6,617 萬 | 1.8% | −250,000−11.5% | 減碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 4,739,004 | $6,587 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 2,752,420 | $6,490 萬 | 1.8% | +1,150,000+71.8% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,827,958 | $6,244 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 6,730,983 | $6,139 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 9,103,054 | $5,890 萬 | 1.6% | −320,161−3.4% | 減碼 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,633,743 | $5,120 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 4,007,413 | $5,101 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 7,064,736 | $4,839 萬 | 1.3% | +3,703,795+110.2% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 4,579,818 | $4,616 萬 | 1.2% | +472,873+11.5% | 加碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 2,739,595 | $3,772 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 5,870,000 | $3,722 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 2,143,036 | $3,667 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 2,742,409 | $3,203 萬 | 0.9% | +2,742,409 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 3,196,701 | $2,893 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 1,846,154 | $2,850 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 4,365,933 | $2,790 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 8,748,629 | $2,703 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,851,051 | $2,631 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,563,963 | $2,515 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 19,995,332 | $2,179 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 7,428,379 | $2,117 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,365,805 | $1,990 萬 | 0.5% | −754,716−24.2% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 8,552,417 | $1,941 萬 | 0.5% | −100,000−1.2% | 減碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,508,416 | $1,483 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $1,432 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 1,521,948 | $1,408 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 1,259,476 | $1,379 萬 | 0.4% | −551,359−30.4% | 減碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 3,169,164 | $1,372 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 1,685,219 | $1,370 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $1,370 萬 | 0.4% | 00.0% | 不變 | – |
| STROSutro Biopharma, Inc. | COM | 3,347,946 | $1,162 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 300,000 | $1,152 萬 | 0.3% | +300,000 | 新進 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,813,633 | $977.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 650,000 | $861.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 6,595,801 | $850.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TCRXTScan Therapeutics, Inc. | COM | 2,989,474 | $765.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM | 9,900,000 | $693.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 6,861,127 | $646.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 20,609,863 | $614.2 萬 | 0.2% | 00.0% | 不變 | – |
| ELDNEledon Pharmaceuticals, Inc. | COM | 4,326,710 | $592.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NLS Pharmaceutics LtdH57830103 | SHS | 5,747,126 | $397.1 萬 | 0.1% | 00.0% | 不變 | – |
| DCTHDelcath Systems, Inc. | COM NEW | 976,149 | $395.3 萬 | 0.1% | −202,638−17.2% | 減碼 | 歷史 |
| KRONKronos Bio, Inc. | COM | 2,905,043 | $377.7 萬 | 0.1% | +91,558+3.3% | 加碼 | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 3,614,662 | $375.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MTEMMolecular Templates, Inc. | COM NEW | 532,038 | $336.2 萬 | 0.1% | +198,934+59.7% | 加碼依 1 比 15 拆股換算 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 3,526,729 | $303.9 萬 | 0.1% | 00.0% | 不變 | – |
| UNCYUnicycive Therapeutics, Inc. | COM | 3,413,563 | $293.6 萬 | 0.1% | +3,413,563 | 新進 | 歷史 |
| IVAInventiva S.A. | ADS | 686,040 | $288.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $200.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FBRXForte Biosciences, Inc. | COM | 2,982,105 | $197.4 萬 | 0.1% | +2,982,105 | 新進 | 歷史 |
| Aslan Pharmaceuticals Ltd04522R200 | SPON ADS NEW | 1,049,999 | $194.2 萬 | 0.1% | 00.0% | 不變 | – |
| MOLNMolecular Partners AG | ADS | 443,221 | $176.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 1,149,425 | $169.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 2,312,200 | $153.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $25.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| BNOXBionomics Ltd | ADS | 47,372 | $12.8 萬 | <0.1% | −33,599−41.5% | 減碼 | 歷史 |
2023 年第 2 季之後清倉（3 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。